These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 837773)

  • 1. Association of halogenated isoxazolylpenicillins with penicillinase-sensitive beta-lactam antibiotics. Microbiological evaluation on beta-lactamase-producing Enterobacteriaceae.
    Ravagnan G; Nicoletti M; Renzini G; Strom R
    Chemotherapy; 1977; 23(3):159-66. PubMed ID: 837773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterobacteria, beta-lactam antibiotics and beta-lactamases in clinical practice.
    Newsom SW; Marshall MJ; Harris AM
    J Med Microbiol; 1974 Nov; 7(4):473-82. PubMed ID: 4615152
    [No Abstract]   [Full Text] [Related]  

  • 3. Joint action of beta-lactam antibiotics.
    Cheung KS; Maniar AC
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):309-15. PubMed ID: 4996194
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-Lactams without a suicide inhibitor.
    Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli.
    Farrar WE; Newsome JK
    Antimicrob Agents Chemother; 1973 Aug; 4(2):109-14. PubMed ID: 4598215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between beta-lactamases production and resistance to beta-lactam antibiotics in clinical isolates of Enterobacteriaceae.
    Romero E; Pagani L; Perduca M; Mignatti P; Malfa S; Mills V
    Microbiologica; 1984 Jul; 7(3):209-18. PubMed ID: 6334220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of Bacillus cereus beta-lactamase by halogenated isoxazolylpenicillins.
    Strom R; Ravagnan G; Salfi V
    Eur J Biochem; 1976 Feb; 62(1):95-101. PubMed ID: 814004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of imipenem on strains of Enterobacteriaceae expressing Richmond & Sykes class I beta-lactamases.
    Ashby J; Kirkpatrick B; Piddock LJ; Wise R
    J Antimicrob Chemother; 1987 Jul; 20(1):15-22. PubMed ID: 3497914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.
    Sala A; Chiarino D; Napoletano M; Albini E; Carenzi A
    Farmaco; 1991; 46(7-8):887-97. PubMed ID: 1793473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the beta-lactam resistance phenotypes of Escherichia coli. An 8-year survey conducted in Greece.
    Neonakis IK; Baritaki S; Georgiladakis A; Spandidos DA
    Roum Arch Microbiol Immunol; 2008; 67(1-2):10-3. PubMed ID: 19284160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
    Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G
    Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of beta-lactamase production and enzyme profiles in Enterobacteriaceae isolated in Moldova.
    Poiată A; Gheorghiu R; Diculencu D; Bosnea D; Păduraru O; Constantiniu S; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 1993; 97(1):429-32. PubMed ID: 8153468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)].
    Schmid B; Kayser FH
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
    MacGowan A
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
    Pottumarthy S; Yu Y; Sader HS; Jones RN; Chen M
    Diagn Microbiol Infect Dis; 2005 Oct; 53(2):131-41. PubMed ID: 15939566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
    Segatore B; Setacci D; Perilli M; Franchino L; Franceschini N; Agnifili A; Rossolini GM; Amicosante G
    Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of six beta-lactam antibiotics against non-beta-lactamase producing and producing enterobacteria and antibiotic resistance transfer.
    Scioli C; Esposito S; Martinelli R
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):338-47. PubMed ID: 6335045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-lactamases of clinical isolates of Enterobacteriaceae family].
    Polishko TM; Skliar TV; Krysenko OV; Vinnikov AI; Kudriavtseva VIe
    Mikrobiol Z; 2011; 73(2):20-5. PubMed ID: 21598655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of resistance to beta-lactam agents in enterobacteriaceae species with group I beta-lactamases in Spain.
    Colom K; Fernández-Aranguiz A; Alonso R; Suinaga E; Cisterna R
    Microb Drug Resist; 1996; 2(3):353-9. PubMed ID: 9158795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.